ACE and endothelial dysfunction: Nevertheless, ACE inhibitors have proven to be potent and effective agents in SHRs for the reduction in blood pressure and regression of several abnormalities, including cardiac and renal hypertrophy and endothelial dysfunction, that are developed in this model of genetic hypertension [57, 58].